
Invitae Investor Relations Material
Latest events

Q3 2023
Invitae
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Invitae Corporation
Access all reports
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people. The company offers clinical and genetic testing services to evaluate the risk of inherited conditions. It also provides diagnostic products and services, including laboratory developed tests and other diagnostic reagents to physicians and hospitals. The company offers hereditary cancer testing services under the Vectra 360 brand, prenatal testing services under the Angelica brand, and germline gene mutation screening under the Genomind brand. The company is based in San Francisco, California.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
NVTA
Country
🇺🇸 United States